Analysts predict surge in ‘blockbuster drugs’ entering the market in 2015Over the next twelve months there will be 11 “blockbuster” drugs entering the market, according to business intelligence company Thomson Reuters.…
FDA approves cholic acid for rare bile acid synthesis disordersCholic acid, a drug used to treat bile acid synthesis disorders and peroxisomal disorders, has been approved by the US Food and Drug Administration.…
The secret life of ketamine Ketamine is being used to treat depression in clinics that are springing up across the United States, but uncertainty remains over its long-term use.…
Saatchi bill defeated at emotionally charged HealthWatch UK debate The Medical Innovation Bill is unnecessary and should not become law, according to medical professionals and lawyers who gathered for a HealthWatch UK debate.…
Clinical research: Regulatory uncertainty hits drug trials in India An avalanche of reforms to rules governing the conduct of clinical trials in India has led to an exodus of drug companies and research organisations.…
US FDA approves drug that prolongs survival in rare paediatric cancer The US Food and Drug Administration has approved dinutuximab as part of first-line therapy for a rare childhood cancer, neuroblastoma. …
FDA grants priority approval for new antifungalIsavuconazonium sulfate, an antifungal developed by Astellas, has been given priority approval by the US Food and Drug Administration to treat serious infections.…
Skin cancer drug fast tracked under early access to medicines schemeA drug for advanced skin cancer, pembrolizumab, has become the first medicine to be fast tracked to patients under the UK’s early access to medicines scheme.…
OTC and dietary products are the most common cause of drug-induced liver injury Drug-induced acute liver failure is uncommon, but over-the-counter products and dietary/herbal supplements are its most common causes, find researchers.…